![]()
|
|
||||||||
(Received for publication, April 19,
1995; and in revised form, July 21, 1995) KDR/flk-1 is one of two receptors for vascular endothelial
growth factor, a potent angiogenic peptide. KDR/flk-1 is an early
marker for endothelial cell progenitors, and its expression is
restricted to endothelial cells in vivo. To investigate the
molecular mechanisms regulating expression of KDR/flk-1, we cloned and
characterized the promoter of the human KDR/flk-1 gene. The
transcription start site was localized by primer extension and
ribonuclease protection to a nucleotide 303 base pairs (bp) 5` of the
initiation methionine codon. The 5`-flanking sequence is rich in G and
C residues and contains five Sp1 elements but no TATA consensus
sequence. By reporter gene transfection experiments, we found that
Volume 270,
Number 39,
Issue of September 29, pp. 23111-23118, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
4 kilobases of KDR/flk-1 5`-flanking sequence directed high level
luciferase activity in bovine aortic endothelial cells; further
deletion analysis revealed positive regulatory elements between bp
-225 to -164, -95 to -77, -77 to
-60, and +105 to +127. Mutation of an atypical GATA
sequence between bp +105 and +127 did not affect promoter
activity, suggesting that GATA elements are not essential for the high
level promoter activity of this gene. Consistent with endothelial
cell-restricted expression of KDR/flk-1 mRNA, we found that the
4-kilobase flanking sequence directed high level promoter activity in
endothelial cells but not in other cell types. To our knowledge this is
the first report characterizing the KDR/flk-1 promoter. Understanding
the KDR/flk-1 promoter will allow us to investigate endothelial
cell-specific gene regulation and to uncover methods for targeting gene
delivery specifically to endothelial cells.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Maeda, T. Suzuki, X. Pan, G. Chen, S. Pan, T. Bartman, and J. A. Whitsett CUL2 Is Required for the Activity of Hypoxia-inducible Factor and Vasculogenesis J. Biol. Chem., June 6, 2008; 283(23): 16084 - 16092. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Higgins, S. Liu, M. Abdelrahim, K. Vanderlaag, X. Liu, W. Porter, R. Metz, and S. Safe Vascular Endothelial Growth Factor Receptor-2 Expression Is Down-Regulated by 17{beta}-Estradiol in MCF-7 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins Mol. Endocrinol., February 1, 2008; 22(2): 388 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Gonzalez-Pacheco, J. J. P. Deudero, M. C. Castellanos, M. A. Castilla, M. V. Alvarez-Arroyo, S. Yague, and C. Caramelo Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2 Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1395 - H1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Higgins, S. Liu, M. Abdelrahim, K. Yoon, K. Vanderlaag, W. Porter, R. P. Metz, and S. Safe Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17{beta}-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins Endocrinology, July 1, 2006; 147(7): 3285 - 3295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.S. Pinsky, W. Song, Z. Dong, K. Warner, B. Zeitlin, E. Karl, D.E. Hall, and J.E. Nor Activation of iCaspase-9 in Neovessels Inhibits Oral Tumor Progression. J. Dent. Res., May 1, 2006; 85(5): 436 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jackson, H. E. Taylor, D. Sharma, S. Desiderio, and S. K. Danoff Vascular Endothelial Growth Factor Receptor-2: COUNTER-REGULATION BY THE TRANSCRIPTION FACTORS, TFII-I AND TFII-IRD1 J. Biol. Chem., August 19, 2005; 280(33): 29856 - 29863. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhattacharya, S. SenBanerjee, Z. Lin, S. Mir, A. Hamik, P. Wang, P. Mukherjee, D. Mukhopadhyay, and M. K. Jain Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2 J. Biol. Chem., August 12, 2005; 280(32): 28848 - 28851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meissner, M. Stein, C. Urbich, K. Reisinger, G. Suske, B. Staels, R. Kaufmann, and J. Gille PPAR{alpha} Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by Repressing Sp1-Dependent DNA Binding and Transactivation Circ. Res., February 20, 2004; 94(3): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, Z. Fang, P. R. Contag, A. F. Purchio, and D. B. West Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse Blood, January 15, 2004; 103(2): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jiang, D. Cyr, R. W. Babbitt, W. C. Sessa, and C. Patterson Chaperone-dependent Regulation of Endothelial Nitric-oxide Synthase Intracellular Trafficking by the Co-chaperone/Ubiquitin Ligase CHIP J. Biol. Chem., December 5, 2003; 278(49): 49332 - 49341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan and C. D. Sigmund HPRT Targeting: "Ets" A Powerful Tool For Investigating Endothelial-Cell Specific Gene Expression Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1960 - 1962. [Full Text] [PDF] |
||||
![]() |
T. Minami, J. A. Kuivenhoven, V. Evans, T. Kodama, R. D. Rosenberg, and W. C. Aird Ets Motifs Are Necessary for Endothelial Cell-Specific Expression of a 723-bp Tie-2 Promoter/Enhancer in Hprt Targeted Transgenic Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2041 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, M. Moser, V. L. Bautch, and C. Patterson HoxB5 Is an Upstream Transcriptional Switch for Differentiation of the Vascular Endothelium from Precursor Cells Mol. Cell. Biol., August 15, 2003; 23(16): 5680 - 5691. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Chun, H. Itoh, L. Subramanian, J. A. Iniguez-Lluhi, and K. Nakao Modification of GATA-2 Transcriptional Activity in Endothelial Cells by the SUMO E3 Ligase PIASy Circ. Res., June 13, 2003; 92(11): 1201 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrecque, I. Royal, D. S. Surprenant, C. Patterson, D. Gingras, and R. Beliveau Regulation of Vascular Endothelial Growth Factor Receptor-2 Activity by Caveolin-1 and Plasma Membrane Cholesterol Mol. Biol. Cell, January 1, 2003; 14(1): 334 - 347. [Abstract] [Full Text] |
||||
![]() |
T. Minami, D. J. Donovan, J. C. Tsai, R. D. Rosenberg, and W. C. Aird Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase-targeted mice Blood, December 1, 2002; 100(12): 4019 - 4025. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Gargett, M. Zaitseva, K. Bucak, S. Chu, P. J. Fuller, and P. A. W. Rogers 17{beta}-Estradiol Up-Regulates Vascular Endothelial Growth Factor Receptor-2 Expression in Human Myometrial Microvascular Endothelial Cells: Role of Estrogen Receptor-{alpha} and -{beta} J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4341 - 4349. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi and M. Tsujimoto Characterization of the Human Gene Encoding the Scavenger Receptor Expressed by Endothelial Cell and Its Regulation by a Novel Transcription Factor, Endothelial Zinc Finger Protein-2 J. Biol. Chem., June 28, 2002; 277(27): 24014 - 24021. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Abumiya, T. Sasaguri, Y. Taba, Y. Miwa, and M. Miyagi Shear Stress Induces Expression of Vascular Endothelial Growth Factor Receptor Flk-1/KDR Through the CT-Rich Sp1 Binding Site Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 907 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aitsebaomo, M. L. Kingsley-Kallesen, Y. Wu, T. Quertermous, and C. Patterson Vezf1/DB1 Is an Endothelial Cell-specific Transcription Factor That Regulates Expression of the Endothelin-1 Promoter J. Biol. Chem., October 12, 2001; 276(42): 39197 - 39205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Nicklin, P. N. Reynolds, M. J. Brosnan, S. J. White, D. T. Curiel, A. F. Dominiczak, and A. H. Baker Analysis of Cell-Specific Promoters for Viral Gene Therapy Targeted at the Vascular Endothelium Hypertension, July 1, 2001; 38(1): 65 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Robinson and S. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell Sci., January 3, 2001; 114(5): 853 - 865. [Abstract] [PDF] |
||||
![]() |
A. Kappel, T. M. Schlaeger, I. Flamme, S. H. Orkin, W. Risau, and G. Breier Role of SCL/Tal-1, GATA, and Ets transcription factor binding sites for the regulation of Flk-1 expression during murine vascular development Blood, November 1, 2000; 96(9): 3078 - 3085. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. FOSTER, P. WIESEL, G. S. HUGGINS, R. PAÑARES, M. T. CHIN, A. PELLACANI, and M. A. PERRELLA Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1{beta} in vascular smooth muscle cells FASEB J, February 1, 2000; 14(2): 368 - 378. [Abstract] [Full Text] |
||||
![]() |
G. Meduri, P. Bausero, and M. Perrot-Applanat Expression of Vascular Endothelial Growth Factor Receptors in the Human Endometrium: Modulation During the Menstrual Cycle Biol Reprod, February 1, 2000; 62(2): 439 - 447. [Abstract] [Full Text] |
||||
![]() |
A. K. Gupta, V. Ruvolo, C. Patterson, and S. Swaminathan The Human Herpesvirus 8 Homolog of Epstein-Barr Virus SM Protein (KS-SM) Is a Posttranscriptional Activator of Gene Expression J. Virol., January 1, 2000; 74(2): 1038 - 1044. [Abstract] [Full Text] |
||||
![]() |
K. Maemura, C.-M. Hsieh, M. K. Jain, S. Fukumoto, M. D. Layne, Y. Liu, S. Kourembanas, S.-F. Yet, M. A. Perrella, and M.-E. Lee Generation of a Dominant-negative Mutant of Endothelial PAS Domain Protein 1 by Deletion of a Potent C-terminal Transactivation Domain J. Biol. Chem., October 29, 1999; 274(44): 31565 - 31570. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Tsopanoglou and M. E. Maragoudakis On the Mechanism of Thrombin-induced Angiogenesis. POTENTIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR ACTIVITY ON ENDOTHELIAL CELLS BY UP-REGULATION OF ITS RECEPTORS J. Biol. Chem., August 20, 1999; 274(34): 23969 - 23976. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kappel, V. Ronicke, A. Damert, I. Flamme, W. Risau, and G. Breier Identification of Vascular Endothelial Growth Factor (VEGF) Receptor-2 (Flk-1) Promoter/Enhancer Sequences Sufficient for Angioblast and Endothelial Cell-Specific Transcription in Transgenic Mice Blood, June 15, 1999; 93(12): 4284 - 4292. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ballinger, P. Connell, Y. Wu, Z. Hu, L. J. Thompson, L.-Y. Yin, and C. Patterson Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions Mol. Cell. Biol., June 1, 1999; 19(6): 4535 - 4545. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Karantzoulis-Fegaras, H. Antoniou, S.-L. M. Lai, G. Kulkarni, C. D'Abreo, G. K. T. Wong, T. L. Miller, Y. Chan, J. Atkins, Y. Wang, et al. Characterization of the Human Endothelial Nitric-oxide Synthase Promoter J. Biol. Chem., January 29, 1999; 274(5): 3076 - 3093. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu and C. Patterson The Human KDR/flk-1 Gene Contains a Functional Initiator Element That Is Bound and Transactivated by TFII-I J. Biol. Chem., January 29, 1999; 274(5): 3207 - 3214. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giraudo, L. Primo, E. Audero, H.-P. Gerber, P. Koolwijk, S. Soker, M. Klagsbrun, N. Ferrara, and F. Bussolino Tumor Necrosis Factor-alpha Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells J. Biol. Chem., August 21, 1998; 273(34): 22128 - 22135. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Foster, B. M. Arkonac, N. E. S. Sibinga, C. Shi, M. A. Perrella, and E. Haber Regulation of CD44 Gene Expression by the Proinflammatory Cytokine Interleukin-1beta in Vascular Smooth Muscle Cells J. Biol. Chem., August 7, 1998; 273(32): 20341 - 20346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hata, E. Duh, K. Zhang, G. S. Robinson, and L. P. Aiello Transcription Factors Sp1 and Sp3 Alter Vascular Endothelial Growth Factor Receptor Expression through a Novel Recognition Sequence J. Biol. Chem., July 24, 1998; 273(30): 19294 - 19303. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Cowan, D. Tsang, C. M. Pedic, L. R. Abbott, T. A. Shinkel, A. J.F. d'Apice, and M. J. Pearse The Human ICAM-2 Promoter is Endothelial Cell-specific in Vitro and in Vivo and Contains Critical Sp1 and GATA Binding Sites J. Biol. Chem., May 8, 1998; 273(19): 11737 - 11744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, L. Xia, and R. P. McEver Comparison of Promoters for the Murine and Human P-selectin Genes Suggests Species-specific and Conserved Mechanisms for Transcriptional Regulation in Endothelial Cells J. Biol. Chem., April 17, 1998; 273(16): 10058 - 10067. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Otani, H. Takagi, K. Suzuma, and Y. Honda Angiotensin II Potentiates Vascular Endothelial Growth Factor–Induced Angiogenic Activity in Retinal Microcapillary Endothelial Cells Circ. Res., March 23, 1998; 82(5): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Arkonac, L. C. Foster, N. E. S. Sibinga, C. Patterson, K. Lai, J.-C. Tsai, M.-E. Lee, M. A. Perrella, and E. Haber Vascular Endothelial Growth Factor Induces Heparin-binding Epidermal Growth Factor-like Growth Factor in Vascular Endothelial Cells J. Biol. Chem., February 20, 1998; 273(8): 4400 - 4405. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Gerber, F. Condorelli, J. Park, and N. Ferrara Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes. Flt-1, BUT NOT Flk-1/KDR, IS UP-REGULATED BY HYPOXIA J. Biol. Chem., September 19, 1997; 272(38): 23659 - 23667. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garlanda and E. Dejana Heterogeneity of Endothelial Cells : Specific Markers Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1193 - 1202. [Abstract] [Full Text] |
||||
![]() |
C. Patterson, Y. Wu, M.-E. Lee, J. D. DeVault, M. S. Runge, and E. Haber Nuclear Protein Interactions with the Human KDR/flk-1 Promoter in Vivo. REGULATION OF Sp1 BINDING IS ASSOCIATED WITH CELL TYPE-SPECIFIC EXPRESSION J. Biol. Chem., March 28, 1997; 272(13): 8410 - 8416. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ronicke, W. Risau, and G. Breier Characterization of the Endothelium-Specific Murine Vascular Endothelial Growth Factor Receptor-2 (Flk-1) Promoter Circ. Res., August 1, 1996; 79(2): 277 - 285. [Abstract] [Full Text] |
||||
![]() |
April. M. Henderson, S.-Jen. Wang, Angela. C. Taylor, M. Aitkenhead, and C. C. W. Hughes The Basic Helix-Loop-Helix Transcription Factor HESR1 Regulates Endothelial Cell Tube Formation J. Biol. Chem., February 23, 2001; 276(9): 6169 - 6176. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Minami, R. D. Rosenberg, and W. C. Aird Transforming Growth Factor-beta 1-mediated Inhibition of the flk-1/KDR Gene Is Mediated by a 5'-Untranslated Region Palindromic GATA Site J. Biol. Chem., February 9, 2001; 276(7): 5395 - 5402. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |